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Changes in fatty acid patterns may explain many of the observed abnormalities found in
obstructive jaundice. This study looked at fatty acids in plasma cholesterol esters, in a group of
patients with obstructive jaundice and a matched group of controls. Significant abnormalities
were demonstrated, most importantly a fall in essential fatty acids, in the jaundiced group.
Overall the saturation of this fraction, as assessed by double bond index, rose. The essential fatty
acids are important as factors in membrane function and as precursors of eicosanoids. The
abnormalities found in this study provide further evidence of the significance ofEFA in patients
with obstructive jaundice.
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INTRODUCTION
The underlying cause ofthe many abnormalities found
in obstructive jaundice is still unclear. As outcome has
been associated with many of the abnormalities, their
aetiology is important. We have investigated many
aspects of fatty acid status in obstructivejaundice. Our
central hypothesis is that fatty acid abnormalities are
responsible for the cellular dysfunction known to oc-
cur, in many systems, in obstructive jaundice. The
reticuloendothelial system seems particularly import-
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The pattern of plasma cholesterol ester fatty acids is abnormal in
obstructive jaundice. Scriven MW, Stewart JCM, Horrobin, DF,
Puntis, MCA. HPB Surgery 1992;5 (Suppl): 32.
ant. The aim of the present study was to establish the
pattern of fatty acids in an important plasma fraction,
in patients with obstructive jaundice.
MATERIALS AND METHODS
42 patients admitted for elective surgery, for benign
conditions, made up the control group. None of these
patients had any history of jaundice or other hepa-
tobiliary disorders. Similarly, none had any condition
or predisposition known to affect fatty acid patterns,
such as atopy or diabetes mellitus. All had normal liver
function tests.
The jaundiced group comprised 42 patients with
extrahepatic biliary obstruction. 12 had bile duct gall
stones and 30 had compression from tumours. 6 of the
tumours were metastastatic-from stomach (2), breast (1),
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oesophagus (1), rectum (1) and an unknown primary
(2). The remaining 24 had pancreatic carcinomas (13),
cholangiocarcinomas (8) ampullary carcinomas (2) and
gall bladder carcinoma (1). None of the jaundiced
patients had any other condition or predisposition
known to cause fatty acid changes.
The two groups were well matched for age, sex and
weight (Table 1). The mean plasma bilirubin for the
jaundiced group was 247 micromol/1 (range 39-540)
and the mean plasma alkaline phosphatase was 823
IU/1 (range 233-3060). As stated previously, the liver
function tests of the control patients were normal.
Venesection was undertaken in the morning, using
a large bore needle without a tourniquet. These pre-
cautions were to try and minimise the potential effects
of platelet aggregation and diurnal variation, on fatty
acid patterns. Plasma was separated by centrifugation.
and stored at -70C until analysis.
After thawing, lipid was extracted. The plasma cho-
lesterol ester fraction was then separated and extrac-
ted, by thin layer chromatography. The methylated
fatty acids in this fraction were then measured by fully
automated packed-column gas liquid chromatogra-
phy. The details of these methods have been described
previously 1. The results, as molar percentages, were
then analysed using a microcomputer. To aid the
interpretation of the results a number of variables were
calculated. The use of these variables is necessary
because no single fatty acid level gives an indication of
fatty acid status. Their use has been reviewed (2). The
variables include totals for groups of fatty acids, for
instance total saturated fatty acids (SFA), and the
double bond index (DBI). DBI is the mean number of
double bonds per fatty acid. The n-6 and n-3 fatty
acids constitute the essential fatty acids (EFA), which,
in humans, are synonymous with the polyunsaturated
fatty acids (PUFA). Statistical analysis was undertaken
using two sample Student’s t-tests.
RESULTS
)’he results are shown in Tables 2 and 3. The fatty acids
in Table 2 are the major ones in the plasma cholesterol
ester fraction-others are detectable but only in very
small concentrations. In these tables the ratios of the
mean results for the jaundice to control patients are
given. The ratios for the calculated variables are shown
graphically in Figure 1.
Similar analysis was undertaken to compare the 12
patients with jaundice due to gall stones, with the 30
with jaundice due to malignant disease. There was no
significant difference (data not shown).
DISCUSSION
Table 1 Basic details of the patients in each group
Sex Age Weioht (Kg)
(median (range)) mean (95% CI)
Controls patients 23M: 19F
Jaundiced patients 23M: 19F
63 (37-87) 70.8 (66.6-75.1)
69 (22-88) 67.8 (62.9-72.8)
Using a two sample Student’s t-test no statistical difference was
found between the weights or ages of the two groups. 95% CI-95%
confidence interval.
Many abnormalities have been described in obstruc-
tive jaundice. Some, such as immune and reticulo-
endothelial dysfunction, seem important in the major
complications these patients suffer3. Others, in
particular changes in plasma bile pigments and liver
enzymes, are useful clinically. However, the fundamen-
tal cause of the poor outcome in these patients is still
unclear.
Table 2 Fatty acid results
Controls 95% Confidence Jaundiced
Mean Interval Mean
95% Confidence p Ratio of
Interval Jaundice: Control*
16:0 10:82 (10.04-11.61) 11.05
18:0 0.95 (0.54-1.36) 0.80
18:ln-9 17.82 (16.84-18.80) 23.77
18:2n-6 51.45 (49.09-53.81) 43.22
20:3n-6 0.76 (0.63-0.87) 0.39
20:4n-6 6.36 (5.76-6.97) 6.37
20:5n-3 1.21 (0.94-1.47) 0.77
22:6n-3 0.94 (0.43-1.45) 0.51
(10.59-11.51) > 0.100 1.02
(0.65-0.96) > 0.100 0.84
(22.20-25.33) < 0.001 1.33
(40.82-45.63) < 0.001 0.84
(0.30-0.47) < 0.001 0.51
(5.64-7.11) > 0.100 1.00
(0.61-0.93) 0.006 0.64
(0.38-0.63) 0.100 0.54
*-Ratio of the mean for the jaundice patients to the mean for the controls
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Table 3 Calculated variable results
Mean Group Controls Mean Group 2: Jaundiced p Ratio of
95//o Confidence 95% Confidence Naundice: Control*
Interval Interval
SFA 12.31 (11.16-13.46) 12.33 (11.78-12.88) > 0.100 1.00
MUFA 22.20 (21.01-23.39) 32.24 (29.75-34.72) < 0.001 1.45
EFA 63.07 (61.16-64.99) 53.44 (50.57-56.31) < 0.001 0.85
DBI 1.72 (1.69-1.75) 1.59 (1.54-1.64) < 0.001 0.93
Total (n-6) 59.90 (57.59-62.21) 51.40 (48.56-54.23) < 0.001 0.86
Total (n-3) 3.02 (2.44-3.60) 1.91 (1.56-2.27) 0.002 0.63
18C-EFA 53.34 (51.03-55.65) 44.86 (42.42-47.29) <0.001 0.84
20C-EFA 8.51 (7.75-9.28) 7.71 (6.87-8.55) >0.100 0.91
* -Ratio of the mean for the jaundice patients to the mean for the controls
The results are shown as molar percentages. Statistical analysis by Student’s t-test
EFA-essential fatty acids, PUFA-polyunsaturated fatty acids, MUFA-monounsaturated fatty acids, SFA-saturated fatty
acids, DBI-double bond index, 18C-EFA-18 carbon EFA, 20C-EFA-20 carbon EFA.
MUFA EFA DBI Total (n-6) Total(n-S) 18C-E FA 20C-E FA 22C-EPA
Figure 1 The chart shows the ratios of the mean results of the jaundice to control patients, from Table 3. *- difference between the two
groups statistically significant (p < 0.002). EFA-essential fatty acids, PUFA-polyunsaturated fatty acids, MUFA-monounsaturated fatty
acids, SFA-saturated fatty acids, DBI-double bond index, 18C-EFA-18 carbon EFA, 20C-EFA-20 carbon EFA.
Fatty acids, in particular EFA, have important roles
in the control ofmembrane function and as precursors
of the eicosanoids’’5. Consequently, abnormalities in
fatty acid patterns have profound effects on many
systems. Reticuloendothelial cells are particularly sen-
sitive to changes in fatty acid patterns6-9. The present
study was part of a wider investigation of EFA in
obstructive jaundice.
A number of highly significant abnormalities was
shown. In summary there was a fall in EFA and
a corresponding rise in monounsaturated fatty acids
(MUFA), in thejaundiced group. The changes affected244 M.W. SCRIVEN
both n-6 and n-3 fatty acids. Of the three major
eicosanoid precursors, eicosapentaenoic (20: 5n- 3) and
dihomo-gamma-linolenic acids (20"3n-6) were lower
than controls. Arachidonic acid (20:4n-6) was not
different from controls. Overall, these changes were
reflected as a fall in double bond index.
The direction of these changes is consistent with the
hypothesis that fatty acid abnormalities underlie many
of the changes in obstructive jaundice, especially those
in reticuloendothelial function.
The aetiology ofthe fatty acid abnormalities was not
investigated in this study. Possibilities include malab-
sorption of EFA and dysfunction of hepatic fatty acid
desaturase enzymes. There was no difference between
the patients with benignjaundice and those with malig-
nant jaundice, indicating that biliary obstruction itself
is more important than its cause.
A new biochemical abnormality has been demon-
strated in obstructive jaundice. The changes are con-
sistent with those demonstrated in other lipid
fractions o and add to growing evidence ofthe import-
ance of EFA in patients with obstructive jaundice.
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